Global shift: Rethinking Hormonal Treatments for Minors
Table of Contents
A growing number of countries and institutions are re-evaluating guidelines surrounding hormonal treatments for minors experiencing gender dysphoria, sparking intense debate and legal challenges.
Brazil Reverses Course on hormonal Therapy
In a significant policy shift, Brazil’s Federal council of Medicine (CFM), the regulatory body overseeing medical standards nationwide, has reversed its previous stance on hormonal treatments for minors. Previously, the CFM had authorized such treatments for individuals as young as 16, but a recent decision published in the Official Journal now prohibits these therapies for anyone under the age of 18. Furthermore, the CFM has raised the minimum age for gender reassignment surgeries with potentially sterilizing effects from 18 to 21.
This decision arrives amidst increasing legislative pressure. Several bills are currently under consideration in the Brazilian parliament, dominated by conservative voices, that propose criminal penalties for doctors who provide hormonal treatments to minors.
International Trend Towards Caution
Brazil’s decision reflects a broader international trend. Several nations that initially permitted hormonal interventions for minors experiencing gender dysphoria are now adopting a more cautious approach, frequently enough citing concerns about long-term effects and the potential for regret.
Sweden, for example, made the decision in 2022 to largely discontinue hormone therapy for minors, except in extremely rare and carefully considered cases, emphasizing a principle of “prudence.” This shift followed a review of available evidence and a growing debate within the Swedish medical community.
…the authorities decided in 2022 to end hormone therapy for minors, except in very rare cases, by ‘prudence’.
Legal Battles and Shifting Definitions
The debate extends beyond medical guidelines and into the legal arena. In the United States, approximately half of the states have enacted legislation restricting or prohibiting hormonal treatments for minors. The Supreme Court is poised to rule by June on the constitutionality of these restrictions, a decision that could have far-reaching implications for access to gender-affirming care nationwide.
Adding another layer of complexity, legal definitions of gender are also being challenged.The British Supreme Court recently ruled that the legal definition of “woman” is based on biological sex, not gender identity. This ruling underscores the ongoing tension between transgender rights advocates and those who believe that some transgender rights claims may infringe upon the rights of women.
…the legal definition of a woman was based on biological sex and not gender.
The Broader Context: Understanding Gender Dysphoria
These policy changes and legal battles occur against the backdrop of increasing awareness and understanding of gender dysphoria. According to the American Psychiatric Association,gender dysphoria involves a conflict between a person’s physical or assigned gender and the gender with wich they identify. While the prevalence of gender dysphoria is arduous to determine precisely, studies suggest that it affects a small but significant portion of the population, particularly among adolescents and young adults.
The debate surrounding hormonal treatments for minors is complex and multifaceted, involving medical ethics, legal considerations, and deeply held beliefs about gender identity. As more data emerges and societal attitudes evolve, it is indeed likely that these discussions will continue to shape policies and practices around the world.
